Latest News

  • INNOVATION

    14 Nov 2025

    Can Tiny Injections Replace Big Infusions

  • TECHNOLOGY

    12 Nov 2025

    AI Redesigns How America Makes Its Medicines

  • PARTNERSHIPS

    11 Nov 2025

    Allies in Innovation: The Rise of Drug Delivery Partnerships

  • RESEARCH

    7 Nov 2025

    Nanoform and Takeda Bet on Miniature Science

The Next Big Breakthrough in Biologics Starts at Home

The Next Big Breakthrough in Biologics Starts at Home

INNOVATION

5 Nov 2025

Halozyme’s Elektrofi buy brings next-gen innovation to biologic drug delivery

Nanoparticles targeting cells in Wyss Institute’s ENTER non-viral delivery innovation

INNOVATION

22 Jun 2025

Can These Nanoparticles Outsmart Your Cells?

Wyss Institute’s nanoparticle system improves precision and safety in non-viral gene and mRNA therapies

Microscopic view of cancer cells representing rise of injectable subcutaneous cancer therapies

MARKET TRENDS

16 Jun 2025

Fast-Track Cancer Care: Injections Replace IV Drips

Sanofi and Bristol Myers embrace subcutaneous delivery as infusion-based therapies give way to quicker, patient-friendly alternatives

Implant Could End Eye Drops: A New Era in Glaucoma Treatment

INVESTMENT

6 Jun 2025

Implant Could End Eye Drops: A New Era in Glaucoma Treatment

US start-up advances device replacing daily drops with sustained-release therapy

Scientists analyzing AI-driven drug research data in Persist AI’s automated cloud laboratory

TECHNOLOGY

31 May 2025

AI Cloud Labs Are Reshaping Drug Development Fast

Persist AI’s cloud lab speeds up drug R&D with AI and robotics, offering faster, cheaper formulation without traditional labs.

3D render of blue bioink cells showing Caltech’s ultrasound-based drug delivery innovation

INNOVATION

15 May 2025

Drug Delivery Without a Cut? Caltech’s Ultrasound Fix

Ultrasound-triggered implants may reduce need for surgery and reshape future of targeted therapy

Ajinomoto Bio-Pharma Services building acquired by PCI Pharma for US biotech expansion

PARTNERSHIPS

9 May 2025

From mRNA to ADCs: PCI Bets Big on Biotech Boom

Pharma firm PCI buys Althea site to boost US production of next-gen injectables like ADCs and mRNA therapies.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.